Keyphrases
Chemobrain
100%
Chemotherapy
100%
Chemotherapy Regimen
33%
Chemotherapy-induced
33%
Cisplatin
33%
Cognitive Decline
66%
Cognitive Functioning
33%
Cognitive Impairment
33%
Etoposide
33%
Lung Cancer Treatment
33%
Negative Effects
33%
Neurocognitive Function
33%
Neuropsychological Tests
33%
Non-small Cell Lung Cancer (NSCLC)
100%
Non-small Cell Lung Cancer Patients
33%
Patient Demographics
33%
Post-chemotherapy
33%
Potential Loss
33%
Prospective pilot Study
100%
Psychological Tests
33%
Quality of Life Assessment
33%
Radiation Therapy
33%
Radiotherapy
33%
Radiotherapy Alone
33%
Specific Patient
33%
Stage III Non-small Cell Lung Cancer
66%
Survival Benefit
33%
Transient State
100%
Treatment Assessment
33%
Untoward Effect
33%
Nursing and Health Professions
Cancer Chemotherapy
33%
Cisplatin
33%
Cognitive Defect
33%
Etoposide
33%
Neuropsychological Test
33%
Non Small Cell Lung Cancer
100%
Patient Population
33%
Pilot Study
100%
Psychologic Test
33%
Quality of Life Measure
33%
Radiotherapy
100%
Psychology
Cognitive Decline
100%
Cognitive Functioning
50%
Cognitive Impairment
50%
Mood
50%
Neurocognitive Function
50%
Psychology
50%
Quality of Life Measure
50%
Pharmacology, Toxicology and Pharmaceutical Science
Cancer Chemotherapy
20%
Chemotherapy
100%
Chemotherapy Regimens
20%
Cisplatin
20%
Cognitive Defect
20%
Etoposide
20%
Non Small Cell Lung Cancer
100%
Neuroscience
Chemotherapy Regimens
33%
Cisplatin
33%
Cognitive Disorders
33%
Etoposide
33%
Neuropsychological Test
33%
Radiation Therapy
100%